|
1
|
Basu S: Bioactive eicosanoids: Role of
prostaglandin F(2α) and F2-isoprostanes in inflammation
and oxidative stress related pathology. Mol Cells. 30:383–391.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fernández-Sánchez A, Madrigal-Santillán E,
Bautista M, Esquivel-Soto J, Morales-González A, Esquivel-Chirino
C, Durante-Montiel I, Sánchez-Rivera G, Valadez-Vega C and
Morales-González JA: Inflammation, oxidative stress, and obesity.
Int J Mol Sci. 12:3117–3132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valko M, Rhodes CJ, Moncol J, Izakovic M
and Mazur M: Free radicals, metals and antioxidants in oxidative
stress-induced cancer. Chem Biol Interact. 160:1–40. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xia C, Meng Q, Liu L-Z, Rojanasakul Y,
Wang X-R and Jiang B-H: Reactive oxygen species regulate
angiogenesis and tumor growth through vascular endothelial growth
factor. Cancer Res. 67:10823–10830. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Stouffs M, Serrander L, Banfi B,
Bettiol E, Charnay Y, Steger K, Krause KH and Jaconi ME: The NADPH
oxidase NOX4 drives cardiac differentiation: Role in regulating
cardiac transcription factors and MAP kinase activation. Mol Biol
Cell. 17:3978–3988. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kovac S, Angelova PR, Holmström KM, Zhang
Y, Dinkova-Kostova AT and Abramov AY: Nrf2 regulates ROS production
by mitochondria and NADPH oxidase. Biochim Biophys Acta.
1850:794–801. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang F, Zhang Y and Dusting GJ: NADPH
oxidase-mediated redox signaling: Roles in cellular stress
response, stress tolerance, and tissue repair. Pharmacol Rev.
63:218–242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meitzler JL, Antony S, Wu Y, Juhasz A, Liu
H, Jiang G, Lu J, Roy K and Doroshow JH: NADPH oxidases: A
perspective on reactive oxygen species production in tumor biology.
Antioxid Redox Signal. 20:2873–2889. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Juhasz A, Ge Y, Markel S, Chiu A,
Matsumoto L, van Balgooy J, Roy K and Doroshow JH: Expression of
NADPH oxidase homologues and accessory genes in human cancer cell
lines, tumours and adjacent normal tissues. Free Radic Res.
43:523–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rao Malla R, Raghu H and Rao JS:
Regulation of NADPH oxidase (Nox2) by lipid rafts in breast
carcinoma cells. Int J Oncol. 37:1483–1493. 2010.PubMed/NCBI
|
|
11
|
Bedard K, Jaquet V and Krause K-H: NOX5:
From basic biology to signaling and disease. Free Radic Biol Med.
52:725–734. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ziche M, Morbidelli L, Choudhuri R, Zhang
HT, Donnini S, Granger HJ and Bicknell R: Nitric oxide synthase
lies downstream from vascular endothelial growth factor-induced but
not basic fibroblast growth factor-induced angiogenesis. J Clin
Invest. 99:2625–2634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mattila JT and Thomas AC: Nitric oxide
synthase: Non-canonical expression patterns. Front Immunol.
5:4782014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lander HM, Jacovina AT, Davis RJ and
Tauras JM: Differential activation of mitogen-activated protein
kinases by nitric oxide-related species. J Biol Chem.
271:19705–19709. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alblas J, Honing H, de Lavalette CR, Brown
MH, Dijkstra CD and van den Berg TK: Signal regulatory protein
alpha ligation induces macrophage nitric oxide production through
JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH
oxidase/H2O2-dependent pathways. Mol Cell
Biol. 25:7181–7192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ranganathan S, Krishnan A and
Sivasithambaram ND: Significance of twist and iNOS expression in
human breast carcinoma. Mol Cell Biochem. 412:41–47. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Delledonne M, Zeier J, Marocco A and Lamb
C: Signal interactions between nitric oxide and reactive oxygen
intermediates in the plant hypersensitive disease resistance
response. Proc Natl Acad Sci USA. 98:pp. 13454–13459. 2001;
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sáinz N, Barrenetxe J, Moreno-Aliaga MJ
and Martínez JA: Leptin resistance and diet-induced obesity:
Central and peripheral actions of leptin. Metabolism. 64:35–46.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garonna E, Botham KM, Birdsey GM, Randi
AM, Gonzalez-Perez RR and Wheeler-Jones CPD: Vascular endothelial
growth factor receptor-2 couples cyclo-oxygenase-2 with
pro-angiogenic actions of leptin on human endothelial cells. PLoS
One. 6:e188232011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ehrhardt RA, Foskolos A, Giesy SL,
Wesolowski SR, Krumm CS, Butler WR, Quirk SM, Waldron MR and
Boisclair YR: Increased plasma leptin attenuates adaptive
metabolism in early lactating dairy cows. J Endocrinol.
229:145–157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park HK and Ahima RS: Physiology of
leptin: energy homeostasis, neuroendocrine function and metabolism.
Metabolism. 64:24–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bouloumie A, Marumo T, Lafontan M and
Busse R: Leptin induces oxidative stress in human endothelial
cells. FASEB J. 13:1231–1238. 1999.PubMed/NCBI
|
|
23
|
Bilbao MG, Di Yorio MP, Galarza RA, Varone
CL and Faletti AG: Regulation of the ovarian oxidative status by
leptin during the ovulatory process in rats. Reproduction.
149:357–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bourgeais J, Gouilleux-Gruart V and
Gouilleux F: Oxidative metabolism in cancer: A STAT affair?
JAK-STAT. 2:e257642013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dattaroy D, Pourhoseini S, Das S, Alhasson
F, Seth RK, Nagarkatti M, Michelotti GA, Diehl AM and Chatterjee S:
Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via
leptin-mediated NADPH oxidase in experimental and human
nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver
Physiol. 308:G298–G312. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nalabolu MR, Palasamudram K and Jamil K:
Adiponectin and leptin molecular actions and clinical significance
in breast cancer. Int J Hematol Oncol Stem Cell Res. 8:31–40.
2014.PubMed/NCBI
|
|
27
|
Naviglio S, Di Gesto D, Illiano F, Chiosi
E, Giordano A, Illiano G and Spina A: Leptin potentiates
antiproliferative action of cAMP elevation via protein kinase A
down-regulation in breast cancer cells. J Cell Physiol.
225:801–809. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dubois V, Jardé T, Delort L, Billard H,
Bernard-Gallon D, Berger E, Geloen A, Vasson MP and Caldefie-Chezet
F: Leptin induces a proliferative response in breast cancer cells
but not in normal breast cells. Nutr Cancer. 66:645–655. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vona-Davis L and Rose DP: The
obesity-inflammation-eicosanoid axis in breast cancer. J Mammary
Gland Biol Neoplasia. 18:291–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Andò S and Catalano S: The multifactorial
role of leptin in driving the breast cancer microenvironment. Nat
Rev Endocrinol. 8:263–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo S, Liu M, Wang G, Torroella-Kouri M
and Gonzalez-Perez RR: Oncogenic role and therapeutic target of
leptin signaling in breast cancer and cancer stem cells. Biochim
Biophys Acta. 1825:207–222. 2012.PubMed/NCBI
|
|
32
|
Badid N, Ahmed FZB, Merzouk H, Belbraouet
S, Mokhtari N, Merzouk SA, Benhabib R, Hamzaoui D and Narce M:
Oxidant/antioxidant status, lipids and hormonal profile in
overweight women with breast cancer. Pathol Oncol Res. 16:159–167.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Blanquer-Rosselló MM, Santandreu FM,
Oliver J, Roca P and Valle A: Leptin modulates mitochondrial
function, dynamics and biogenesis in MCF-7 cells. J Cell Biochem.
116:2039–2048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schmidt S, Monk JM, Robinson LE and
Mourtzakis M: The integrative role of leptin, oestrogen and the
insulin family in obesity-associated breast cancer: Potential
effects of exercise. Obes Rev. 16:473–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martínez-Martínez E, Jurado-López R,
Valero-Muñoz M, Bartolomé MV, Ballesteros S, Luaces M, Briones AM,
López-Andrés N, Miana M and Cachofeiro V: Leptin induces cardiac
fibrosis through galectin-3, mTOR and oxidative stress: Potential
role in obesity. J Hypertens. 32:1104–1114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grossmann ME, Ray A, Nkhata KJ, Malakhov
DA, Rogozina OP, Dogan S and Cleary MP: Obesity and breast cancer:
Status of leptin and adiponectin in pathological processes. Cancer
Metastasis Rev. 29:641–653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jardé T, Caldefie-Chézet F,
Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F and
Vasson MP: Involvement of adiponectin and leptin in breast cancer:
Clinical and in vitro studies. Endocr Relat Cancer. 16:1197–1210.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Woolley JF, Stanicka J and Cotter TG:
Recent advances in reactive oxygen species measurement in
biological systems. Trends Biochem Sci. 38:556–565. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schefe JH, Lehmann KE, Buschmann IR, Unger
T and Funke-Kaiser H: Quantitative real-time RT-PCR data analysis:
Current concepts and the novel ‘gene expression's CT difference’
formula. J Mol Med (Berl). 84:901–910. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Minta A, Kao JP and Tsien RY: Fluorescent
indicators for cytosolic calcium based on rhodamine and fluorescein
chromophores. J Biol Chem. 264:8171–8178. 1989.PubMed/NCBI
|
|
41
|
Rossary A, Arab K, Goudable J and Steghens
JP: Fatty acids regulate NOX activity. Ann Biol Clin (Paris).
65:33–40. 2007.(In French). PubMed/NCBI
|
|
42
|
Rossary A, Arab K and Steghens J-P:
Polyunsaturated fatty acids modulate NOX 4 anion superoxide
production in human fibroblasts. Biochem J. 406:77–83. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lamas B, Vergnaud-Gauduchon J,
Goncalves-Mendes N, Perche O, Rossary A, Vasson M-P and Farges M-C:
Altered functions of natural killer cells in response to L-Arginine
availability. Cell Immunol. 280:182–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Graham KA, Kulawiec M, Owens KM, Li X,
Desouki MM, Chandra D and Singh KK: NADPH oxidase 4 is an
oncoprotein localized to mitochondria. Cancer Biol Ther.
10:223–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li J-M and Shah AM: ROS generation by
nonphagocytic NADPH oxidase: Potential relevance in diabetic
nephropathy. J Am Soc Nephrol. 14 Suppl 3:S221–S226. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cave AC, Brewer AC, Narayanapanicker A,
Ray R, Grieve DJ, Walker S and Shah AM: NADPH oxidases in
cardiovascular health and disease. Antioxid Redox Signal.
8:691–728. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Antony S, Wu Y, Hewitt SM, Anver MR,
Butcher D, Jiang G, Meitzler JL, Liu H, Juhasz A, Lu J, et al:
Characterization of NADPH oxidase 5 expression in human tumors and
tumor cell lines with a novel mouse monoclonal antibody. Free Radic
Biol Med. 65:497–508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dho SH, Kim JY, Kwon E-S, Lim JC, Park SS
and Kwon K-S: NOX5-L can stimulate proliferation and apoptosis
depending on its levels and cellular context, determining cancer
cell susceptibility to cisplatin. Oncotarget. 6:39235–39246. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen F, Wang Y, Barman S and Fulton DJR:
Enzymatic regulation and functional relevance of NOX5. Curr Pharm
Des. 21:5999–6008. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Aldieri E, Riganti C, Polimeni M, Gazzano
E, Lussiana C, Campia I and Ghigo D: Classical inhibitors of NOX
NAD(P)H oxidases are not specific. Curr Drug Metab. 9:686–696.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Petrônio MS, Zeraik ML, Fonseca LM and
Ximenes VF: Apocynin: Chemical and biophysical properties of a
NADPH oxidase inhibitor. Molecules. 18:2821–2839. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ameri K, Jahangiri A, Rajah AM, Tormos KV,
Nagarajan R, Pekmezci M, Nguyen V, Wheeler ML, Murphy MP, Sanders
TA, et al: HIGD1A regulates oxygen consumption, ROS production, and
AMPK activity during glucose deprivation to modulate cell survival
and tumor growth. Cell Rep. 10:891–899. 2015. View Article : Google Scholar
|
|
53
|
Martín-Romero C and Sánchez-Margalet V:
Human leptin activates PI3K and MAPK pathways in human peripheral
blood mononuclear cells: Possible role of Sam68. Cell Immunol.
212:83–91. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Trachootham D, Lu W, Ogasawara MA, Nilsa
RD and Huang P: Redox regulation of cell survival. Antioxid Redox
Signal. 10:1343–1374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nourazarian AR, Kangari P and Salmaninejad
A: Roles of oxidative stress in the development and progression of
breast cancer. Asian Pac J Cancer Prev. 15:4745–4751. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen F, Yu Y, Haigh S, Johnson J, Lucas R,
Stepp DW and Fulton DJR: Regulation of NADPH oxidase 5 by protein
kinase C isoforms. PLoS One. 9:e884052014. View Article : Google Scholar : PubMed/NCBI
|
